⏳
Showing Q3 2024 data
SC ISRAEL IV GENPAR, LTD.'s Q4 2025 filing not yet available. Expected by Feb 14, 2026.
SC ISRAEL IV GENPAR, LTD.
•CIK: 1611353•Filing: Q3 2024
**SC ISRAEL IV GENPAR, LTD.** manages $17M, exhibiting a highly concentrated portfolio structure. The fund's current holdings are entirely weighted toward NTRSO, representing a single, dominant position accounting for the full $17.5M of its assets. This singular focus suggests a conviction-driven, high-conviction investment thesis centered on the selected issuer.
Total AUM
$17.5M
QoQ Performance
N/A
Positions
1
Top 10 Concentration
100.0%
Latest Filing
Q3 2024
Top Holdings Allocation
INNO
INNOVID100.0%
📈 Biggest Buys
—
INNOVID CORP
NEW
100.0% of portfolio
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other100.0%